Domains of delirium severity in Alzheimer's disease and related dementias. Issue 5 (24th December 2021)

• Record Type: Journal Article
• Authors: Schulman‐Green, Dena; Hshieh, Tammy; Adamis, Dimitrios; Avidan, Michael S.; Blazer, Dan G.; Fick, Donna M.; Oh, Esther; Morandi, Alessandro; Price, Catherine; Verghese, Joe; Schmitt, Eva M.; Jones, Richard N.; Inouye, Sharon K.
• Is Part Of: Journal of the American Geriatrics Society. Volume 70:Issue 5(2022)
• Page Start: 1495
• Page End: 1503
• Publication Date: 2021-12-24
• Subjects: ADRD -- delirium -- dementia -- expert panel -- instrument; Geriatrics -- Periodicals; 618.97
• DOI: 10.1111/jgs.17624
• Languages: English
• ISSNs: 0002-8614

Abstract

Abstract: Background: The ability to rate delirium severity is key to providing optimal care for persons with Alzheimer's Disease and Related Dementias (ADRD). Such ratings would allow clinicians to assess response to treatment, recovery time and prognosis, nursing burden and staffing needs, and to provide nuanced, appropriate patient‐centered care. Given the lack of existing tools, we defined content domains for a new delirium severity instrument for use in individuals with mild to moderate ADRD, the DEL‐S‐AD. Methods: We built upon our previous study in which we created a content domain framework to inform development of a general delirium severity instrument, the DEL‐S. We engaged a new expert panel to discuss issues of measurement in delirium and dementia and to determine which content domains from the prior framework were useful in characterizing delirium severity in ADRD. We also asked panelists to identify new domains. Our panel included eight interdisciplinary members with expertise in delirium and dementia. Panelists participated in two rounds of review followed by two surveys over 2 months. Results: Panelists endorsed the same content domains as for general delirium severity, including Cognitive, Level of Consciousness, Inattention, Psychiatric‐Behavioral, Emotional Dysregulation, Psychomotor Features, and Functional; however, they excluded six of the original subdomains which they considered unhelpful in the context of ADRD: cognitive impairment; anxiety; fear/sense of unease; depression; gait/walking; and incontinence. Debated measurement challenges included assessment at one point in time versus over time, accounting for differences in clinical settings, and accurate assessment of symptoms related to delirium versus dementia. Conclusions: By capturing a range of characteristics of delirium severity potentially present in patients with ADRD, a population that may already have attention, functional, and emotional changes at baseline, the DEL‐S‐AD provides a novel rating tool that will be useful for clinical and research purposes to improve patient care.